Brief: Oncocyte Posts Q3 Loss Per Share Of $0.15
Nov 9 (Reuters) - OncoCyte Corp OCX.O :
* ONCOCYTE REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATE
* Q3 LOSS PER SHARE $0.15
* Q3 REVENUE $1.0 MILLION
* Q3 EARNINGS PER SHARE VIEW $-0.12, REVENUE VIEW $1.8
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX13c9RR
Further company coverage: OCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission